Skip to main navigation
Telix Pharmaceuticals Limited Logo
  • Overview
  • News
  • Events & Presentations
    • Events
    • Presentations
  • Financials
    • Half-year & Quarterly Results
    • Annual Reports & AGMs
    • ASX Announcements
    • SEC Filings
  • Pipeline
  • Stock
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Board & Management
    • Documents & Charters
    • Sustainability
  • Resources
    • Shareholder Information
    • Investor Resources
    • Email Alerts
    • Contact Us

ASX Announcements

Date Title
05 Nov 2026
Appendix 3Y Maria Rivas
04 Nov 2026
Telix Capital Markets Day Presentation November 2026
03 Nov 2026
Change of Director's Interest Notice - Marie McDonald
03 Nov 2026
Notification regarding unquoted securities - TLX
03 Nov 2026
Cancellation of Appendix 2A
30 Oct 2026
Telix Notice of General Meeting, Proxy Form and Online Guide
28 Oct 2026
Application for quotation of securities - TLX
27 Oct 2026
Appendix 3Y Dr Christian Behrenbruch
26 Oct 2026
Appendix 3Y William Jellison
26 Oct 2026
Appendix 3Y Change in Director Interest - D Gill
  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page ›
  • Last page »
Displaying 1 - 10 of 123

Subscribe to our Email Alerts

©2026 Telix Pharmaceuticals Limited.

The Telix Pharmaceuticals and the Illuccix name and logo are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. This website is intended for corporate communication and investor relations purposes only and is not intended as promotion or advertising to any audience in any country worldwide.

Privacy Policy. Terms of Use. Cookies Policy. Forward Looking Statements
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube
Search Investors